JCM Figure table search 04
Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Müller, D.
Right arrow Articles by Schmidt, M. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Müller, D.
Right arrow Articles by Schmidt, M. A.

 Previous Article  |  Next Article 

Journal of Clinical Microbiology, July 2006, p. 2626-2629, Vol. 44, No. 7
0095-1137/06/$08.00+0     doi:10.1128/JCM.00895-06
Copyright © 2006, American Society for Microbiology. All Rights Reserved.

Rapid Identification and Differentiation of Clinical Isolates of Enteropathogenic Escherichia coli (EPEC), Atypical EPEC, and Shiga Toxin-Producing Escherichia coli by a One-Step Multiplex PCR Method

Daniel Müller,1 Peter Hagedorn,1 Sabine Brast,1 Gerhard Heusipp,1 Martina Bielaszewska,2 Alexander W. Friedrich,2 Helge Karch,2 and M. Alexander Schmidt1*

Institut für Infektiologie, Zentrum für Molekularbiologie der Entzündung, Westfälische Wilhelms-Universität/ Universitätsklinikum Münster,1 Institut für Hygiene und Nationales Konsiliarlaboratorium für Hämolytisch-Urämisches Syndrom, Universitätsklinikum Münster, D-48149 Münster, Germany2

Received 28 April 2006/ Accepted 3 May 2006

Enteropathogenic Escherichia coli (EPEC), atypical enteropathogenic E. coli, and Shiga toxin-producing E. coli differ in their virulence factor profiles, clinical manifestations, and prognosis, and they require different therapeutic measures. We developed and evaluated a robust multiplex PCR to identify these pathogroups based on sequences complementary to escV, bfpB, stx1, and stx2.

* Corresponding author. Mailing address: Institut für Infektiologie, Zentrum für Molekularbiologie der Entzündung (ZMBE), Von-Esmarch-Str. 56, D-48149 Münster, Germany. Phone: 49 251 835 6466. Fax: 49 251 835 6467. E-mail: infekt{at}uni-muenster.de.

Journal of Clinical Microbiology, July 2006, p. 2626-2629, Vol. 44, No. 7
0095-1137/06/$08.00+0     doi:10.1128/JCM.00895-06
Copyright © 2006, American Society for Microbiology. All Rights Reserved.



This article has been cited by other articles:



Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
Antimicrob. Agents Chemother. Clin. Microbiol. Rev.
Clin. Vaccine Immunol. ALL ASM JOURNALS

Copyright © 2006 by the American Society for Microbiology. All rights reserved.